CV DEATH HAS A NEW OPPONENT
CV DEATH HAS A NEW OPPONENT

Empagliflozin (JARDIANCE) is safe for HF patients without T2D

Document ID: PC-PH-104047

06/12/2022

Author: Boehringer Ingelheim

Related content

 
PC-PH-104047
Production date: December 2022